These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34513144)

  • 1. Volumetric analysis of subthalamic nucleus and red nucleus in patients of advanced Parkinson's disease using SWI sequences.
    Kolpakwar S; Arora AJ; Pavan S; Kandadai RM; Alugolu R; Saradhi MV; Borgohain R
    Surg Neurol Int; 2021; 12():377. PubMed ID: 34513144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3T MRI-SWI based volumetric analysis of the subthalamic and red nuclei in advanced Parkinson's disease.
    Shah V; Alugolu R; Arora A; Kandadai RM; Mudumba V; Borgohain R
    J Neurosurg Sci; 2023 Feb; 67(1):108-112. PubMed ID: 32401475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
    Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
    J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motoric impairment versus iron deposition gradient in the subthalamic nucleus in Parkinson's disease.
    Huang W; Ogbuji R; Zhou L; Guo L; Wang Y; Kopell BH
    J Neurosurg; 2021 Jul; 135(1):284-290. PubMed ID: 32764171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conventional MRI is inadequate to delineate the relationship between the red nucleus and subthalamic nucleus in Parkinson's disease.
    Danish SF; Jaggi JL; Moyer JT; Finkel L; Baltuch GH
    Stereotact Funct Neurosurg; 2006; 84(1):12-8. PubMed ID: 16636641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volumetric analysis of the subthalamic and red nuclei based on magnetic resonance imaging in patients with Parkinson's disease.
    Camlidag I; Kocabicak E; Sahin B; Jahanshahi A; Incesu L; Aygun D; Yildiz O; Temel Y; Belet U
    Int J Neurosci; 2014 Apr; 124(4):291-5. PubMed ID: 24020352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T2-relaxometry predicts outcome of DBS in idiopathic Parkinson's disease.
    Lönnfors-Weitzel T; Weitzel T; Slotboom J; Kiefer C; Pollo C; Schüpbach M; Oertel M; Kaelin A; Wiest R
    Neuroimage Clin; 2016; 12():832-837. PubMed ID: 27843765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: a new approach for active contact localization.
    Garcia-Garcia D; Guridi J; Toledo JB; Alegre M; Obeso JA; Rodríguez-Oroz MC
    J Neurosurg; 2016 Nov; 125(5):1068-1079. PubMed ID: 26848922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism.
    Plaha P; Ben-Shlomo Y; Patel NK; Gill SS
    Brain; 2006 Jul; 129(Pt 7):1732-47. PubMed ID: 16720681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subthalamic Stimulation for Camptocormia in Parkinson's Disease: Association of Volume of Tissue Activated and Structural Connectivity with Clinical Effectiveness.
    Lai Y; Song Y; Huang P; Wang T; Wang L; Pan Y; Sun Q; Sun B; Zhang C; Li D
    J Parkinsons Dis; 2021; 11(1):199-210. PubMed ID: 33325395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of subthalamic nuclei T2 relaxation times with neuropsychological symptoms in patients with Parkinson's disease.
    Watanabe S; Suenaga K; Yamamoto A; Abe K; Kotoura N; Ishikura R; Hirota S; Yoshikawa H
    J Neurol Sci; 2012 Apr; 315(1-2):96-9. PubMed ID: 22123154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1.5T versus 3T MRI for targeting subthalamic nucleus for deep brain stimulation.
    Cheng CH; Huang HM; Lin HL; Chiou SM
    Br J Neurosurg; 2014 Aug; 28(4):467-70. PubMed ID: 24191703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacies of globus pallidus stimulation and subthalamic nucleus stimulation for advanced Parkinson's disease: a meta-analysis of randomized controlled trials.
    Tan ZG; Zhou Q; Huang T; Jiang Y
    Clin Interv Aging; 2016; 11():777-86. PubMed ID: 27382262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral subthalamic deep brain stimulation initial impact on nonmotor and motor symptoms in Parkinson's disease: An open prospective single institution study.
    Kurcova S; Bardon J; Vastik M; Vecerkova M; Frolova M; Hvizdosova L; Nevrly M; Mensikova K; Otruba P; Krahulik D; Kurca E; Sivak S; Zapletalova J; Kanovsky P
    Medicine (Baltimore); 2018 Feb; 97(5):e9750. PubMed ID: 29384860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subthalamic and red nucleus volumes in patients with Parkinson's disease: do they change with disease progression?
    Colpan ME; Slavin KV
    Parkinsonism Relat Disord; 2010 Jul; 16(6):398-403. PubMed ID: 20452266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.
    Paek SH; Han JH; Lee JY; Kim C; Jeon BS; Kim DG
    Neurosurgery; 2008 Nov; 63(5):925-36; discussion 936-7. PubMed ID: 19005383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial.
    Odekerken VJ; van Laar T; Staal MJ; Mosch A; Hoffmann CF; Nijssen PC; Beute GN; van Vugt JP; Lenders MW; Contarino MF; Mink MS; Bour LJ; van den Munckhof P; Schmand BA; de Haan RJ; Schuurman PR; de Bie RM
    Lancet Neurol; 2013 Jan; 12(1):37-44. PubMed ID: 23168021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of 3T Magnetic Resonance Imaging for Targeting the Human Subthalamic Nucleus in Deep Brain Stimulation for Parkinson Disease.
    Longhi M; Ricciardi G; Tommasi G; Nicolato A; Foroni R; Bertolasi L; Beltramello A; Moretto G; Tinazzi M; Gerosa M
    J Neurol Surg A Cent Eur Neurosurg; 2015 May; 76(3):181-9. PubMed ID: 25764475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.